Lumenis Showcases Its Advanced CO2 Solutions for Throat Cancer With Transoral Laser Microsurgery at the AAO-HNSF Annual Meeting

YOKNEAM, ISRAEL--(Marketwired - Sep 21, 2014) - Lumenis Ltd. (NASDAQ: LMNS), the world's largest energy-based medical company for surgical, ophthalmology and aesthetic applications, showcases its novel CO₂ laser AcuPulse™ DUO, along with a wide range of fibers and accessories, at the Academy of Otolaryngology - Head and Neck Surgery (AAO-HNSF) 2014 Annual Meeting, which takes place September 21-24^th in Orlando, Florida. Lumenis exhibits at booth #829 throughout the meeting.

Tzipi Ozer-Armon, CEO of Lumenis, stated: "Our commitment to delivering the advanced and versatile ENT solutions for physicians and patients was the driving force behind the development of the AcuPulse DUO, our flagship platform for head and neck surgery. This advanced product solution perfectly embodies our mission of brininging better technologies for better patient care in the ENT domain. I am also pleased to say that thus far we have received outstanding feedback from surgeons regarding the performance of the AcuPulse DUO. Furthermore, as evident from mounting clinical data, this product significantly improves access to transoral laser microsurgery, or TLM, which can help preserve throat cancer patients' facial appearance and protect the ability to function normally."

Throat cancer is the second most common cancer in the upper aerodigestive tract, with over 12,000 new cases a year in the United States and nearly 3,000 annual deaths.¹ The use of chemotherapy, radiation therapy, or cold knife surgery in the treatment of transoral airway cancer is associated with complications. Alternatively, TLM offers low morbidity and excellent cure rates compared to chemoradiation.² Patients treated with TLM have no risk of radiation-associated side effects. Overall treatment and recovery time are faster than with radiation. Moreover, after receiving radiation as the first-line treatment, many patients may no longer be able to undergo minimally invasive procedures if the first round of radiation therapy is unsuccessful. The only option then is radical surgery, often requiring removal of the whole voice box, resulting in loss of voice. With TLM, the option of repeated minimally invasive surgery interventions and even radiation therapy remains, if necessary.